Press releases, Investors Press releases, Investors17 April 202617 April 2026parDIAGNOS DIAGNOS-nomme-Dr-Ismail-Ben-Ayed-PhD-au-poste-de-Scientifique-en-Chef-Intelligence-Artificielle-IA-pour-accelerer-linnovation-en-sante Post navigation Previous PostDIAGNOS-Provides-Additional-Information-on-Amendment-to-Convertible-Debentures-1 Next PostDIAGNOS-Appoints-Dr.-Ismail-Ben-Ayed-PhD-as-Chief-Artificial-Intelligence-AI-Scientist-to-Accelerate-our-Innovation-in-Healthcare Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS Announces a Three Year Contract Renewal with Optina Diagnostics" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 09 2021 DIAGNOS DIAGNOS Announces a Three Year Contract Renewal with Optina Diagnostics Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-deposera-une-demande-dautorisation-de-pre-commercialisation-aupres-de-la-FDA-pour-son-systeme-CARA-" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 02 2025 DIAGNOS DIAGNOS deposera une demande dautorisation de pre commercialisation aupres de la FDA pour son systeme CARA Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2022 DIAGNOS DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS Announces a Three Year Contract Renewal with Optina Diagnostics" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 09 2021 DIAGNOS DIAGNOS Announces a Three Year Contract Renewal with Optina Diagnostics Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-deposera-une-demande-dautorisation-de-pre-commercialisation-aupres-de-la-FDA-pour-son-systeme-CARA-" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 02 2025 DIAGNOS DIAGNOS deposera une demande dautorisation de pre commercialisation aupres de la FDA pour son systeme CARA Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2022 DIAGNOS DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening Download PDF
